| Literature DB >> 35162118 |
Juan-Miguel Guerras1,2, María-José Belza2,3, María-José Fuster4,5, Luis de la Fuente1,2, Patricia García de Olalla2,6, David Palma2,6, Jorge-Néstor García-Pérez7, Juan Hoyos8.
Abstract
This study assessed the knowledge and prior use of HIV self-testing in a sample of men who have sex with men (MSM) recruited in a sexual health clinic and two community-based testing sites in Madrid and Barcelona, >12 months after its legal authorization. Between March 2019 and December 2020, we recruited 2044 MSM. Participants completed a self-administered questionnaire while waiting to be tested for HIV and other STIs. We built two Poisson regression models to assess factors associated with prior knowledge and with use. Among those who had used self-testing in the past we assessed frequency of use and several aspects related to the last testing episode. The proportion of participants that knew about the existence of self-testing and had already used it was of 26.3% and 5.1% respectively. Both, knowledge and use were independently associated with being born in Spain or other western European countries, university education and more recent HIV testing. Additionally, knowledge was associated with older age, having a more favorable economic situation, and not living sexuality in total secrecy. Use was also associated with having received money in exchange for sex. Most (69.5%) reported having self-tested once, 64.8% had self-tested <12 months ago, 63.8% self-tested alone and 71.4% acquired the kit at a pharmacy over the counter. In spite of its authorization and becoming legally available, knowledge and use of HIV self-testing remain low among MSM attending sites specialized in the diagnosis of HIV and other STIs. When designing scale-up strategies, lower levels of knowledge and use in less favored subgroups of MSM need to be factored in.Entities:
Keywords: HIV self-testing (HIVST); early diagnosis; men who have sex with men (MSM)
Mesh:
Year: 2022 PMID: 35162118 PMCID: PMC8834423 DOI: 10.3390/ijerph19031096
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Main characteristics of men who have sex with men recruited in Barcelona and Madrid (n = 2044).
|
| % | |
|---|---|---|
|
| ||
| Madrid community-based program | 949 | 46.4 |
| Barcelona community-based program | 678 | 33.2 |
| Barcelona sexual health clinic | 417 | 20.4 |
|
| ||
| <30 | 740 | 36.2 |
| 30–39 | 722 | 35.3 |
| ≥40 | 582 | 28.5 |
|
| ||
| Latin America | 613 | 30.0 |
| Spain | 1185 | 58.0 |
| Western Europe | 146 | 7.1 |
| Others | 100 | 4.9 |
|
| ||
| Up to primary school | 144 | 7.1 |
| Up to upper secondary | 687 | 33.8 |
| University education | 1203 | 59.1 |
|
| ||
| Difficult/very difficult | 201 | 9.8 |
| Tight | 640 | 31.4 |
| Comfortable/good | 1200 | 58.8 |
|
| 1601 | 78.6 |
|
| ||
| Hidden/in total secrecy | 122 | 6.0 |
| Discreetly | 669 | 32.8 |
| Openly | 1247 | 61.2 |
|
| 1291 | 63.2 |
|
| ||
| 0 | 447 | 25.6 |
| 1 | 582 | 33.4 |
| 2–4 | 503 | 28.9 |
| ≥5 | 211 | 12.1 |
|
| 119 | 5.8 |
|
| 181 | 8.9 |
|
| 253 | 12.4 |
|
| ||
| No STI diagnosis | 887 | 43.8 |
| STI diagnosis > 12 months ago | 543 | 26.8 |
| STI diagnosis in the last 12 months | 594 | 29.3 |
|
| ||
| Never tested before | 123 | 6.0 |
| More than 5 years | 49 | 2.4 |
| 1–5 years | 296 | 14.5 |
| 6–12 months | 602 | 29.5 |
| <6 months | 972 | 47.6 |
* In the last 12 months.
Proportion of participants who know about the existence of HIV self-testing and associated variables (crude and adjusted prevalence ratios).
| Total | Yes | No/Not Sure | CPR * | CI95% ** | APR *** | CI95% | |||
|---|---|---|---|---|---|---|---|---|---|
|
| % |
| % | ||||||
| 537 | 26.3 | 1507 | 73.7 | ||||||
|
| 2 | ||||||||
| Madrid community-based program | 226 | 23.8 | 723 | 76.2 | ref | ||||
| Barcelona community-based program | 175 | 25.8 | 503 | 74.2 | 1.1 | 0.9–1.3 | |||
| Barcelona sexual health clinic | 136 | 32.6 | 281 | 67.4 | 1.4 | 1.1–1.7 | |||
|
| 2 | ||||||||
| <30 | 164 | 22.2 | 576 | 77.8 | ref | ref | |||
| 30–39 | 201 | 27.8 | 521 | 72.2 | 1.3 | 1.0–1.5 | 1.2 | 1.0–1.4 | |
| ≥40 | 172 | 29.6 | 410 | 70.4 | 1.3 | 1.1–1.7 | 1.2 | 1.0–1.5 | |
|
| 1 | ||||||||
| Latin America | 99 | 16.2 | 514 | 83.8 | ref | ref | |||
| Spain | 375 | 31.6 | 810 | 68.4 | 2.0 | 1.6–2.4 | 1.8 | 1.5–2.2 | |
| Western Europe | 44 | 30.1 | 102 | 69.9 | 1.9 | 1.3–2.7 | 1.5 | 1.1–2.1 | |
| Others | 19 | 19.0 | 81 | 81.0 | 1.2 | 0.7–1.9 | 1.1 | 0.7–7.1 | |
|
| 1 | ||||||||
| Below university education | 179 | 21.5 | 652 | 78.5 | ref | ref | |||
| University education | 355 | 29.5 | 848 | 70.5 | 1.4 | 1.1–1.6 | 1.2 | 1.0–1.4 | |
|
| 1 | ||||||||
| Difficult/very difficult | 33 | 16.4 | 168 | 83.6 | ref | ref | |||
| Tight | 138 | 21.6 | 502 | 78.4 | 1.3 | 0.9–1.9 | 1.1 | 0.8–1.5 | |
| Comfortable/good | 365 | 30.4 | 835 | 69.6 | 1.9 | 1.3–2.6 | 1.4 | 1.0–1.9 | |
|
| 1 | ||||||||
| Hidden/in total secrecy | 16 | 13.1 | 106 | 86.9 | ref | ref | |||
| Discreetly | 149 | 22.3 | 520 | 77.7 | 1.7 | 1.0–2.8 | 1.5 | 1.0–2.5 | |
| Openly | 371 | 29.8 | 876 | 70.2 | 2.3 | 1.4–3.7 | 1.9 | 1.2–3.0 | |
|
| 3 | ||||||||
| Men and women | 180 | 23.9 | 573 | 76.1 | ref | ||||
| Only men | 357 | 27.7 | 934 | 72.3 | 1.2 | 1.0–1.4 | |||
|
| 2 | ||||||||
| Yes | 51 | 20.2 | 202 | 79.8 | ref | ||||
| No | 486 | 27.2 | 1304 | 72.8 | 1.3 | 1.0–1.8 | |||
|
| 2 | ||||||||
| Yes | 19 | 16.0 | 100 | 84.0 | ref | ||||
| No | 518 | 26.9 | 1406 | 73.1 | 1.7 | 1.1–2.7 | |||
|
| 1 | ||||||||
| Never tested before | 13 | 10.6 | 110 | 89.4 | ref | ref | |||
| More than 5 years | 14 | 28.6 | 35 | 71.4 | 2.7 | 1.3–5.8 | 2.3 | 1.2–4.7 | |
| 1–5 years | 64 | 21.6 | 232 | 78.4 | 2.0 | 1.1–3.7 | 1.6 | 0.9–2.8 | |
| 6–12 months | 149 | 24.8 | 453 | 75.2 | 2.3 | 1.3–4.1 | 1.8 | 1.1–3.2 | |
| <6 months | 297 | 30.6 | 675 | 69.4 | 2.9 | 1.7–5.0 | 2.4 | 1.4–4.0 | |
The table shows results for variables with a significance level of ≤0.20 in the crude analysis and variables retained in the final model. * Crude prevalence ratio, ** 95% confidence interval, *** adjusted prevalence ratio. 1 p-value < 0.01; 2 p-value < 0.05; 3 p-value ≤ 0.20.
Proportion of participants who reported having used a self-testing kit and associated variables (crude and adjusted prevalence ratios).
| Total | Yes | No | CPR * | CI95% ** | APR *** | CI95% | |||
|---|---|---|---|---|---|---|---|---|---|
|
| % |
| % | ||||||
| 105 | 5.1 | 1939 | 94.9 | ||||||
|
| 4 | ||||||||
| <30 | 33 | 4.5 | 707 | 95.5 | |||||
| 30–39 | 43 | 6.0 | 679 | 94.0 | |||||
| ≥40 | 29 | 5.0 | 553 | 95.0 | |||||
|
| 3 | ||||||||
| Latin America | 24 | 3.9 | 589 | 96.1 | ref | ref | |||
| Spain | 64 | 5.4 | 1121 | 94.6 | 1.4 | 0.9–2.2 | 1.6 | 1.0–2.5 | |
| Western Europe | 14 | 9.6 | 132 | 90.4 | 2.5 | 1.3–4.7 | 2.4 | 1.3–4.6 | |
| Others | 3 | 3.0 | 97 | 97.0 | 0.8 | 0.2–2.5 | 0.8 | 0.3–2.7 | |
|
| 2 | ||||||||
| Below university education | 32 | 3.8 | 799 | 96.2 | ref | ref | |||
| University education | 72 | 6.0 | 1131 | 94.0 | 1.6 | 1.0–2.4 | 1.5 | 1.0–2.3 | |
|
| 3 | ||||||||
| Difficult/very difficult | 6 | 3.0 | 195 | 97.0 | ref | ||||
| Tight | 28 | 4.4 | 612 | 95.6 | 1.5 | 0.6–3.5 | |||
| Comfortable/good | 71 | 5.9 | 1129 | 94.1 | 2.0 | 0.9–4.5 | |||
|
| 3 | ||||||||
| No | 87 | 4.9 | 1703 | 95.1 | ref | ref | |||
| Yes | 18 | 7.1 | 235 | 92.9 | 1.5 | 0.9–2.4 | 1.8 | 1.1–2.9 | |
|
| 1 | ||||||||
| >1 years-never tested | 12 | 2.6 | 456 | 94.8 | ref | ref | |||
| 6–12 months | 25 | 4.1 | 577 | 95.9 | 1.6 | 0.8–3.2 | 1.5 | 0.8–3.0 | |
| <6 months | 68 | 7.0 | 904 | 93.0 | 2.7 | 1.5–5.0 | 2.5 | 1.4–4.6 | |
The table shows results for variables with a significance level of ≤0.20 in the crude analysis and variables retained in the final model. * Crude prevalence ratio, ** 95% confidence interval, *** adjusted prevalence ratio. 1 p-value < 0.01; 2 p-value < 0.05; 3 p-value ≤ 0.20; 4 p-value > 0.20.
Number of self-tests performed, time since last self-test, place of acquisition and companion during last testing episode among participants who had self-tested at least once (n = 105).
|
| % | |
|---|---|---|
|
| ||
| One | 73 | 69.5 |
| Two | 12 | 11.4 |
| Three or more | 20 | 19.0 |
|
| ||
| <3 months | 15 | 14.3 |
| 3 to 12 months | 53 | 50.5 |
| >12 to 24 months | 26 | 24.8 |
| >24 months ago | 11 | 10.5 |
|
| ||
| At a pharmacy (over the counter) | 75 | 71.4 |
| At an online pharmacy | 7 | 6.7 |
| At a country (other than Spain) where it is legally sold | 10 | 9.5 |
| Purchased it on the internet without having certainty about its legality | 1 | 1.0 |
| Others | 12 | 11.4 |
|
| ||
| Alone | 67 | 63.8 |
| Stable partner | 14 | 13.3 |
| Occasional partner | 4 | 3.8 |
| Friend | 13 | 12.4 |
| CBO/NGO staff | 2 | 1.9 |
| Health professional | 5 | 4.8 |